Risultati per: Collegamento dieta ricca di grassi e cancro al colon-retto

All’International Cancer Immunotherapy Conference di Milano focus sull’intelligenza artificiale e al suo impiego nel comprendere i segnali che mettono fuori gioco il sistema immunitario

Evento oggi a Napoli; ‘professionisti importanti nelle equipe’

Ricchi di fosfolipidi eteri dalle proprietà cardio-protettive

Tra i “falsi amici” a tavola la caprese, difficile da digerire

Comunicato del 03/08/2023 n°46

In memoria di una bimba morta a 9 anni.Iniziati i test sull’uomo

To the Editor We read the cohort study assessing the association of inflammatory biomarkers with survival among patients with stage III colon cancer by Cheng et al with some interest. This post hoc analysis of 1494 patients who underwent potentially curative surgical resection and adjuvant chemotherapy for TNM stage III colon cancer showed an association between inflammatory status, recurrence, and mortality. In the context of a multicenter, double-blind, phase 3, adjuvant chemotherapy trial of anti-inflammatory agents, inflammatory status was measured using interleukin 6 (IL-6), tumor necrosis factor (TNF) α receptor 2 (sTNF-αR2), and high-sensitivity C-reactive protein (CRP) levels. The values of the objective biomarkers reported in this large, well-designed cohort study allow comparison with previous studies.

In Reply We thank McGovern et al for their interest in our analysis of inflammatory biomarkers and survival among patients with stage III colon cancer (CALGB/SWOG 80702). In this cohort study, we reported the levels of plasma inflammatory biomarkers, including interleukin 6 (IL-6), soluble tumor necrosis factor α receptor 2 (sTNF-αR2), and high-sensitivity C-reactive protein (CRP). We found that higher inflammation after diagnosis was significantly associated with worse survival among patients with stage III colon cancer.

Proposto da LegaCoop e aperto ad associazioni e istituzioni

Il ministro: “pesano i ritmi e gli stili di vita”